Granted Patent
B2
US 12,697,247 · App. 18/083,427 · Granted Aug 4, 2026
Medical ice slurry production and delivery systems and methods
Inventors:
Lilit Garibyan (Newton, MA); Richard Rox Anderson (Boston, MA); William A. Farinelli (Boston, MA); Emilia Javorsky (Watertown, MA)
Assignee:
The General Hospital Corporation
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present disclosure provides systems and method for medical ice slurry production. In particular, systems and methods are provided for medical ice slurry production that enable an end user to produce and deliver a sterile medical ice slurry at the point of care.
Claims (34)
1 . A method for producing a sterile slurry composition, the method comprising:
receiving a rigid disposable cartridge comprising an access port, wherein a closed environment within the rigid disposable cartridge has been pre-filled with a non-frozen sterile slurry composition;
placing the rigid disposable cartridge within a housing, wherein the housing comprises a cooling device operable to cool the non-frozen sterile slurry composition to a temperature sufficient to form a sterile slurry composition containing a plurality of ice crystals;
cooling the rigid disposable cartridge to a temperature sufficient to form the sterile slurry composition containing the plurality of ice crystals; and
removing the rigid disposable cartridge from the housing;
wherein the non-frozen sterile slurry composition is self-contained within the closed environment during formation of the sterile slurry composition containing the plurality of ice crystals, and
wherein the access port is structured and arranged to allow the sterile slurry composition to be withdrawn or injected from the rigid disposable cartridge, while maintaining the sterility of the sterile slurry composition.
2 . The method of claim 1 , further comprising agitating the sterile slurry composition containing the plurality of ice crystals held in the rigid disposable cartridge such that the plurality of ice crystals are reduced to a size sufficient to allow the sterile slurry composition to be delivered to a patient through an end of a needle operably connected to the rigid disposable cartridge.
3 . The method of claim 1 , wherein the temperature sufficient to form the sterile slurry composition containing the plurality of ice crystals is between about −10° C. and about 4° C.
4 . The method of claim 1 , wherein the non-frozen sterile slurry composition comprises an agent or a biocompatible surfactant.
5 . The method of claim 4 , wherein the agent or biocompatible surfactant is configured to make the sterile slurry composition easier to inject.
6 . The method of claim 1 , wherein the housing comprises an actuator.
7 . The method of claim 1 , wherein the rigid disposable cartridge includes one of a syringe or a canister.
8 . The method of claim 1 , wherein at least one of (i) a luer lock with a shut-off, (ii) a pressure valve, (iii) a quick disconnect, (iv) a one-way valve with luer lock, or (v) a sterile rubber stopper is operable with the access port to selectively allow the sterile slurry composition containing the plurality of ice crystals to be withdrawn from the rigid disposable cartridge through the access port.
9 . A method for producing a sterile slurry composition at a point of care, the method comprising:
receiving a rigid disposable cartridge at the point of care, the rigid disposable cartridge having been pre-filled with a non-frozen sterile slurry composition, wherein the non-frozen sterile slurry composition is self-contained within a closed environment of the rigid disposable cartridge;
cooling the non-frozen sterile slurry composition to a temperature sufficient to form a sterile slurry composition comprising a plurality of ice crystals; and
agitating the sterile slurry composition comprising the plurality of ice crystals such that the plurality of ice crystals are reduced to a size sufficient to allow the sterile slurry composition to be delivered to a patient through an end of a needle operably connected to the rigid disposable cartridge.
10 . The method of claim 9 , wherein the temperature sufficient to form the sterile slurry composition comprising the plurality of ice crystals is between about −10° C. and about 4° C.
11 . The method of claim 9 , wherein the non-frozen sterile slurry composition comprises an agent or a biocompatible surfactant.
12 . The method of claim 11 , wherein the agent or biocompatible surfactant is configured to make the sterile slurry composition comprising the plurality of ice crystals easier to inject.
13 . The method of claim 11 , wherein the non-frozen sterile slurry composition comprises a biocompatible surfactant, and wherein the biocompatible surfactant is glycerol.
14 . The method of claim 9 , wherein the rigid disposable cartridge includes one of a syringe or a canister.
15 . A method for producing a sterile slurry composition, the method comprising:
receiving a rigid disposable cartridge having been pre-filled with a non-frozen sterile slurry composition at a point of care, wherein an access port is defined in the rigid disposable cartridge;
placing the rigid disposable cartridge in a housing, the housing comprising a cooling device operable to cool the non-frozen sterile slurry composition to a temperature sufficient to form a sterile slurry composition comprising a plurality of ice crystals;
cooling the non-frozen sterile slurry composition to the temperature sufficient to form the sterile slurry composition comprising the plurality of ice crystals;
agitating the sterile slurry composition in the rigid disposable cartridge; and
removing the rigid disposable cartridge from the housing.
16 . The method of claim 15 , wherein the temperature sufficient to form the sterile slurry composition is between about −10° C. and about 4° C.
17 . The method of claim 15 , wherein the non-frozen sterile slurry composition comprises an agent or a biocompatible surfactant.
18 . The method of claim 17 , wherein the agent or biocompatible surfactant is configured to make the sterile slurry composition comprising the plurality of ice crystals easier to inject.
19 . The method of claim 15 , wherein the rigid disposable cartridge includes one of a syringe or a canister.
20 . The method of claim 15 , wherein the housing comprises an actuator.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 25, 2026
From: GARIBYAN, LILIT; ANDERSON, RICHARD ROX; FARINELLI, WILLIAM; JAVORSKY, EMILIA
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 075081/0035 →
Continuity (3)
Provisional Application
62300679
· Feb 26, 2016
Related Publication
20230363940A1
· Nov 16, 2023
References Cited (400)
US 4883665A
· Miyazima et al.
· 1989
[cited by applicant]
US 4986079A
· Koseki et al.
· 1991
[cited by applicant]
US 5005364A
· Nelson
· 1991
[cited by applicant]
US 5143063A
· Fellner
· 1992
[cited by applicant]
US 5507790A
· Weiss
· 1996
[cited by applicant]
US 5769879A
· Richards et al.
· 1998
[cited by applicant]
US 6126657A
· Edwards et al.
· 2000
[cited by applicant]
US 6126684A
· Boyden et al.
· 2000
[cited by applicant]
US 6244052B1
· Kasza
· 2001
[cited by applicant]
US 6413444B1
· Kasza
· 2002
[cited by applicant]
US 6430957B1
· Inada et al.
· 2002
[cited by applicant]
US 6962601B2
· Becker et al.
· 2005
[cited by applicant]
US 7160290B2
· Eberl et al.
· 2007
[cited by applicant]
US 7367341B2
· Anderson et al.
· 2008
[cited by applicant]
US 7422601B2
· Becker et al.
· 2008
[cited by applicant]
US 7507234B2
· Utley et al.
· 2009
[cited by applicant]
US 7713266B2
· Elkins et al.
· 2010
[cited by applicant]
US 7892229B2
· Shadduck et al.
· 2011
[cited by applicant]
US 7897141B2
· Wheatley et al.
· 2011
[cited by applicant]
US 7998137B2
· Elkins et al.
· 2011
[cited by applicant]
US 8192474B2
· Levinson
· 2012
[cited by applicant]
US 8298216B2
· Burger et al.
· 2012
[cited by applicant]
US 8337539B2
· Ting et al.
· 2012
[cited by applicant]
US 8480664B2
· Watson et al.
· 2013
[cited by applicant]
US 8505315B2
· Kasza et al.
· 2013
[cited by applicant]
US 8608696B1
· DiMeo et al.
· 2013
[cited by applicant]
US 8672884B2
· Burnett et al.
· 2014
[cited by applicant]
US 8715275B2
· Burger et al.
· 2014
[cited by applicant]
US 8715622B2
· Wheatley et al.
· 2014
[cited by applicant]
US 8840608B2
· Anderson et al.
· 2014
[cited by applicant]
US 8950207B2
· Raines et al.
· 2015
[cited by applicant]
US 9023022B2
· McKay
· 2015
[cited by applicant]
US 9023023B2
· McKay et al.
· 2015
[cited by applicant]
US 9033966B2
· McKay
· 2015
[cited by applicant]
US 9039688B2
· Palmer, III et al.
· 2015
[cited by applicant]
US 9060754B2
· Buckley et al.
· 2015
[cited by applicant]
US 9095320B2
· Littrup et al.
· 2015
[cited by applicant]
US 9101346B2
· Burger et al.
· 2015
[cited by applicant]
US 9131975B2
· McKay
· 2015
[cited by applicant]
US 9295512B2
· Allison et al.
· 2016
[cited by applicant]
US 9320559B2
· McKay
· 2016
[cited by applicant]
US 9345526B2
· Elkins et al.
· 2016
[cited by applicant]
US 9402676B2
· Babkin et al.
· 2016
[cited by applicant]
US 9486267B2
· Burnett et al.
· 2016
[cited by applicant]
US 9492217B2
· Burnett et al.
· 2016
[cited by applicant]
US 9498274B2
· Burnett et al.
· 2016
[cited by applicant]
US 9610112B2
· Karnik et al.
· 2017
[cited by applicant]
US 9655770B2
· Levinson et al.
· 2017
[cited by applicant]
US 9737434B2
· Allison
· 2017
[cited by applicant]
US 9763723B2
· Saadat
· 2017
[cited by applicant]
US 9763743B2
· Lin et al.
· 2017
[cited by applicant]
US 9980076B1
· Avram et al.
· 2018
[cited by applicant]
US 20010005791A1
· Ginsburg et al.
· 2001
[cited by applicant]
US 20020021741A1
· Faries et al.
· 2002
[cited by applicant]
US 20030032996A1
· Hallman
· 2003
[cited by applicant]
US 20030088240A1
· Saadat
· 2003
[cited by applicant]
US 20030125722A1
· Gallo et al.
· 2003
[cited by applicant]
US 20060161232A1
· Kasza et al.
· 2006
[cited by applicant]
US 20070282316A1
· Hennemann et al.
· 2007
[cited by applicant]
US 20080236186A1
· Kasza et al.
· 2008
[cited by applicant]
US 20080247957A1
· Wheatley
· 2008
[cited by applicant]
US 20080279783A1
· Wheatley et al.
· 2008
[cited by applicant]
US 20080300571A1
· Lepivert et al.
· 2008
[cited by applicant]
US 20090028797A1
· Wheatley et al.
· 2009
[cited by applicant]
US 20090118722A1
· Ebbers et al.
· 2009
[cited by applicant]
US 20090234325A1
· Rozenberg et al.
· 2009
[cited by applicant]
US 20090326621A1
· El-Galley
· 2009
[cited by applicant]
US 20100036295A1
· Altshuler et al.
· 2010
[cited by applicant]
US 20100137304A1
· Gilday et al.
· 2010
[cited by applicant]
US 20110009748A1
· Greene et al.
· 2011
[cited by applicant]
US 20130011332A1
· Boyden et al.
· 2013
[cited by applicant]
US 20140200511A1
· Boyden et al.
· 2014
[cited by applicant]
US 20150216719A1
· DeBenedictis et al.
· 2015
[cited by applicant]
US 20160317346A1
· Kovach
· 2016
[cited by applicant]
US 20170274011A1
· Garibyan et al.
· 2017
[cited by applicant]
US 20170274078A1
· Garibyan et al.
· 2017
[cited by applicant]
US 20180185189A1
· Weber et al.
· 2018
[cited by applicant]
US 20180271767A1
· Jimenez Lozano et al.
· 2018
[cited by applicant]
US 20190175243A1
· Keweloh
· 2019
[cited by applicant]
US 20190183558A1
· Anderson et al.
· 2019
[cited by applicant]
US 20200046552A1
· Velis et al.
· 2020
[cited by applicant]
US 20200100935A1
· DeBenedictis et al.
· 2020
[cited by applicant]
US 20200261137A1
· Kalser et al.
· 2020
[cited by applicant]
US 20200297403A1
· Kochavi
· 2020
[cited by applicant]
US 20210322084A1
· Velis et al.
· 2021
[cited by applicant]
US 20210330927A1
· Guzman
· 2021
[cited by applicant]
US 20210346192A1
· Velis et al.
· 2021
[cited by applicant]
US 20210369612A1
· Velis et al.
· 2021
[cited by applicant]
US 20210386580A1
· Velis et al.
· 2021
[cited by applicant]
US 20220008110A1
· Velis et al.
· 2022
[cited by applicant]
US 20220071900A1
· Sabir et al.
· 2022
[cited by applicant]
US 20220226206A1
· Velis et al.
· 2022
[cited by applicant]
US 20220273560A1
· Sabir et al.
· 2022
[cited by applicant]
US 20220273569A1
· Anderson et al.
· 2022
[cited by applicant]
US 20220346852A1
· Anderson et al.
· 2022
[cited by applicant]
US 20220395392A1
· Ting et al.
· 2022
[cited by applicant]
US 20220409428A1
· Guzman
· 2022
[cited by applicant]
US 20230031549A1
· Velis et al.
· 2023
[cited by applicant]
US 20230040940A1
· Levinson
· 2023
[cited by applicant]
US 20230041283A1
· DeBenedictis et al.
· 2023
[cited by applicant]
US 20230046673A1
· Velis et al.
· 2023
[cited by applicant]
US 20230086345A1
· Anderson et al.
· 2023
[cited by applicant]
CN 104406341A
· 2015
[cited by applicant]
CN 204468406U
· 2015
[cited by applicant]
CN 105640642A
· 2016
[cited by applicant]
EP 2561886A1
· 2013
[cited by applicant]
GB 2485864A
· 2012
[cited by applicant]
JP 2003534366A
· 2003
[cited by applicant]
JP 06510758A
· 2006
[cited by applicant]
JP 2008523925A
· 2008
[cited by applicant]
JP 2008545462A
· 2008
[cited by applicant]
JP 2010508130A
· 2010
[cited by applicant]
JP 2011516168A
· 2011
[cited by applicant]
JP 2013539387A
· 2013
[cited by applicant]
JP 2014020596A
· 2014
[cited by applicant]
JP 2014514079A
· 2014
[cited by applicant]
JP 2017526684A
· 2017
[cited by applicant]
WO WO9003795A1
· 1990
[cited by applicant]
WO WO9300930A1
· 1993
[cited by applicant]
WO WO200105372A2
· 2001
[cited by applicant]
WO WO0191720A2
· 2001
[cited by applicant]
WO WO03078596A2
· 2003
[cited by applicant]
WO WO2006066226A1
· 2006
[cited by applicant]
WO WO2006127467A2
· 2006
[cited by applicant]
WO WO2008015380A2
· 2008
[cited by applicant]
WO WO2008055243A2
· 2008
[cited by applicant]
WO WO2009009540A1
· 2009
[cited by applicant]
WO WO2009047362A2
· 2009
[cited by applicant]
WO WO2009102367A2
· 2009
[cited by applicant]
WO WO2009146053A1
· 2009
[cited by applicant]
WO WO2011100692A1
· 2011
[cited by applicant]
WO WO2012027641A2
· 2012
[cited by applicant]
WO WO2012103315A2
· 2012
[cited by applicant]
WO WO2012140439A1
· 2012
[cited by applicant]
WO WO2013059133A1
· 2013
[cited by applicant]
WO WO2015019257A1
· 2015
[cited by applicant]
WO WO2016033380A1
· 2016
[cited by applicant]
WO WO2016033384A1
· 2016
[cited by applicant]
WO WO2017147367A1
· 2017
[cited by applicant]
WO WO2018044825A1
· 2018
[cited by applicant]
WO WO2018160797A1
· 2018
[cited by applicant]
WO WO2020072979A1
· 2020
[cited by applicant]
WO WO2020072983A1
· 2020
[cited by applicant]
WO WO2020077072A1
· 2020
[cited by applicant]
WO WO2020077089A1
· 2020
[cited by applicant]
WO WO2020077090A1
· 2020
[cited by applicant]
WO WO2021133683A1
· 2021
[cited by applicant]
WO WO2021138252A1
· 2021
[cited by applicant]
WO WO2021151019A1
· 2021
[cited by applicant]
WO WO2021247843A1
· 2021
[cited by applicant]
WO WO2022032111A1
· 2022
[cited by applicant]
WO WO2023278891A1
· 2023
[cited by applicant]
WO WO2023034390A1
· 2023
[cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2020/043280 dated Nov. 9, 2020.
[cited by applicant]
International Preliminary Report on Patentability for Application No. PCT/US2020/043280, mailed Feb. 3, 2022.
[cited by applicant]
Extended European Search Report for Application No. EP 22189301.9, mailed Apr. 12, 2023.
[cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2015/047292 dated Dec. 7, 2015.
[cited by applicant]
International Preliminary Report on Patentability mailed Mar. 9, 2017 for Application No. PCT/US2015/047292.
[cited by applicant]
Partial European Search Report mailed Mar. 22, 2018 for Application No. EP 15836780.5.
[cited by applicant]
Extended European Search Report mailed Jun. 26, 2018 for Application No. EP 15836780.5.
[cited by applicant]
Extended European Search Report mailed Mar. 2, 2022 for Application No. EP 21200731.4.
[cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2015/047301 dated Dec. 14, 2015.
[cited by applicant]
International Preliminary Report on Patentability mailed Mar. 9, 2017 for Application No. PCT/US2015/047301.
[cited by applicant]
Partial European Search Report dated Mar. 24, 2020, for Application No. EP 17847238.6.
[cited by applicant]
Extended European Search Report mailed Dec. 7, 2020 for Application No. EP 17847328.6.
[cited by applicant]
International Search Report and Written Opinion mailed Nov. 3, 2017 for Application No. PCT/US2017/048995.
[cited by applicant]
International Preliminary Report on Patentability mailed Mar. 14, 2019 for Application No. PCT/US2017/048995.
[cited by applicant]
Extended European Search Report mailed Aug. 26, 2019 for Application No. EP 17757262.5.
[cited by applicant]
International Search Report and Written Opinion mailed May 15, 2017 for Application No. PCT/US2017/019268.
[cited by applicant]
International Preliminary Report on Patentability mailed Sep. 7, 2018 for Application No. PCT/US2017/019268.
[cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2021/014789 dated May 18, 2021.
[cited by applicant]
International Preliminary Report on Patentability for Application No. PCT/US2021/014789, mailed Aug. 4, 2022.
[cited by applicant]
International Search Report and Written Opinion mailed Apr. 12, 2011 for Application No. PCT/US2011/024766.
[cited by applicant]
International Preliminary Report on Patentability mailed Aug. 30, 2012 for Application No. PCT/US2011/024766.
[cited by applicant]
[No Author Listed], Isotonic (https://biologydictionary.net/isotonic/) accessed Jun. 21, 2018, pp. 1-4 (Year: 2018).
[cited by applicant]
[No Author Listed], Polysorbate-20 (https://web.archive.org/web/20130315082056/http://www.ewg.org:80/skindeep/ingredient/705137/POLYSORBATE-20/) available Mar. 15, 2013, pp. 1-3 (Year: 2013).
[cited by applicant]
[No Author Listed], World Fine Chemicals Handbook. Institute of Science and Technology Information, Ministry of Chemical Industry, Ed. May 31, 1986;187-90.
[cited by applicant]
Abbott et al., Front. Pharmacol. Conference Abstract: Structure and function of the blood-brain barrier. Pharmacology and Toxicology of the Blood-Brain Barrier: State of the Art, Needs for Future Research and Expected B…
[cited by applicant]
Amasheh et al., Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci. Dec. 15, 2002;115(Pt 24):4969-76. doi: 10.1242/jcs.00165.
[cited by applicant]
Antonijevic et al., Perineurial defect and peripheral opioid analgesia in inflammation. J Neurosci. Jan. 1995;15(1 Pt 1):165-72. doi: 10.1523/JNEUROSCI.15-01-00165.1995.
[cited by applicant]
Armitage et al., Toxic and osmotic effects of glycerol on human granulocytes. Am J Physiol. Nov. 1984;247(5 Pt 1):C382-9. doi: 10.1152/ajpcell.1984.247.5.C382.
[cited by applicant]
Ash, Chronic peritoneal dialysis catheters: overview of design, placement, and removal procedures. Semin Dial. Jul.-Aug. 2003;16(4):323-34.
[cited by applicant]
Ballabh et al., The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis. Jun. 2004;16(1):1-13. doi: 10.1016/j.nbd.2003.12.016.
[cited by applicant]
Barnard, The effects of extreme cold on sensory nerves. Ann R Coll Surg Engl. May 1980;62(3):180-7.
[cited by applicant]
Begley, Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol Ther. Oct. 2004;104(1):29-45. doi: 10.1016/j.pharmthera.2004.08.001.
[cited by applicant]
Binshtok et al., Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers. Nature. Oct. 4, 2007;449(7162):607-10. doi: 10.1038/nature06191.
[cited by applicant]
Blasig et al., Occludin protein family: oxidative stress and reducing conditions. Antioxid Redox Signal. Sep. 1, 2011;15(5):1195-219. doi: 10.1089/ars.2010.3542. Epub May 5, 2011.
[cited by applicant]
Blasig et al., On the self-association potential of transmembrane tight junction proteins. Cell Mol Life Sci. Feb. 2006;63(4):505-14. doi: 10.1007/s00018-005-5472-x.
[cited by applicant]
Brink et al., Abdominoplasty with direct resection of deep fat. Plast Reconstr Surg. May 2009;123(5):1597-603. doi: 10.1097/PRS.0b013e3181a07708.
[cited by applicant]
Calandria, Cryoanalgesia for post-herpetic neuralgia: a new treatment. Int J Dermatol. Jun. 2011;50(6):746-50. doi: 10.1111/j.1365-4632.2010.04792.x.
[cited by applicant]
Carruthers et al., Cryolipolysis and skin tightening. Dermatol Surg. Dec. 2014;40 Suppl 12:S184-9. doi: 10.1097/DSS.0000000000000229.
[cited by applicant]
Colegio et al., Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture. Am J Physiol Cell Physiol. Jun. 2003;284(6):C1346-54. doi: 10.1152/ajpce…
[cited by applicant]
Conaway, Ice packs in diabetic neuropathy. Phys Ther Rev. Aug. 1961;41:586-8.
[cited by applicant]
Coyne et al., Role of claudin interactions in airway tight junctional permeability. Am J Physiol Lung Cell Mol Physiol. Nov. 2003;285(5):L1166-78. doi: 10.1152/ajplung.00182.2003. Epub Aug. 8, 2003.
[cited by applicant]
Cukierman et al., Residues in a highly conserved claudin-1 motif are required for hepatitis C virus entry and mediate the formation of cell-cell contacts. J Virol. Jun. 2009;83(11):5477-84. doi: 10.1128/JVI.02262-08. Ep…
[cited by applicant]
Cuschieri et al., Hypertonic preconditioning inhibits macrophage responsiveness to endotoxin. J Immunol. Feb. 1, 2002;168(3):1389-96. doi: 10.4049/jimmunol.168.3.1389.
[cited by applicant]
Ding et al., Association between non-subcutaneous adiposity and calcified coronary plaque: a substudy of the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr. Sep. 2008;88(3):645-50.
[cited by applicant]
Dogan et al., Microstructural Control of Complex-Shaped Ceramics Processed by Freeze Casting. CFI Ceramic Forum International. May 2002;79(5);E35(1-4).
[cited by applicant]
Dua et al., Liposome: Methods of Preparation and Applications. Int J. Pharm Stud Res. Apr. 2012; 3(2): 14-20.
[cited by applicant]
Foster et al., Sympathetic but not sensory denervation stimulates white adipocyte proliferation. Am J Physiol Regul Integr Comp Physiol. Dec. 2006;291(6):R1630-7. doi: 10.1152/ajpregu.00197.2006. Epub Aug. 3, 2006.
[cited by applicant]
Fox et al., Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. Jul. 3, 2007;116(1):39-48. Epub Jun. 18, 2007.
[cited by applicant]
Fried et al., Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. Sep. 26, 2002;347(13):975-82. doi: 10.1056/NEJMoa020047.
[cited by applicant]
Fruhstorfer et al., The effects of thermal stimulation on clinical and experimental itch. Pain. Feb. 1986;24(2):259-69.
[cited by applicant]
Fujita et al., Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett. Jul. 7, 2000;476(3):258-61. doi: 10.1016/s0014-5793(00)01744…
[cited by applicant]
Fujita et al., Permeability characteristics of tetragastrins across intestinal membranes using the Caco-2 monolayer system: comparison between acylation and application of protease inhibitors. Pharm Res. Sep. 1998;15(9)…
[cited by applicant]
Furuse et al., A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J Cell Biol. Oct. 19, 1998;143(2):391-401. doi: 10.1083/jcb.143.2.391.
[cited by applicant]
Furuse et al., Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol. Mar. 18, 2002;156(6):1099-111. doi: 10.1083/jcb.200110122. Epub Mar. 11,…
[cited by applicant]
Furuse et al., Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol. Dec. 1993;123(6 Pt 2):1777-88. doi: 10.1083/jcb.123.6.1777.
[cited by applicant]
Gage et al., Experimental cryosurgery investigations in vivo. Cryobiology. Dec. 2009;59(3):229-43. doi: 10.1016/j.cryobiol.2009.10.001. Epub Oct. 13, 2009.
[cited by applicant]
Garaulet et al., Relationship between fat cell size and No. and fatty acid composition in adipose tissue from different fat depots in overweight/obese humans. Int J Obes (Lond). Jun. 2006;30(6):899-905.
[cited by applicant]
Garbay et al., Myelin synthesis in the peripheral nervous system. Prog Neurobiol. Jun. 2000;61(3):267-304.
[cited by applicant]
Garibyan et al., Neural Selective Cryoneurolysis with Ice Slurry Injection in a Rat Model. Anesthesiology. Jul. 2020;133(1):185-194. doi: 10.1097/ALN.0000000000003124.
[cited by applicant]
Garibyan et al., Subcutaneous Fat Reduction with Injected Ice Slurry. Plast Reconstr Surg. Apr. 2020;145(4):725e-733e. doi: 10.1097/PRS.0000000000006658.
[cited by applicant]
Garibyan et al., Selective Removal of Adipose Tissue by Injection of Physiological Ice Slurry. Plast Reconstr Surg. Apr. 2020;145(4):725e-733e. doi: 10.1097/PRS.0000000000006658. Supplemental Materials. 8 pages.
[cited by applicant]
Ge et al., Calculations of Freezing Point Depression, Boiling Point Elevation, Vapor Pressure and Enthalpies of Vaporization of Electrolyte Solutions by a Modified Three-Characteristic Parameter Correlation Model. J Sol…
[cited by applicant]
Ge et al., Estimation of Freezing Point Depression, Boiling Point Elevation, and Vaporization Enthalpies of Electrolyte Solutions. Ind Eng Chem Res. Jan. 15, 2009;48(4):2229-35.
[cited by applicant]
Gradinger et al., Abdominoplasty. The Art of Aesthetic Surgery: Principles and Techniques. Foad Nahai ed., 1st Ed. 2005. 74 pages.
[cited by applicant]
Graham et al., Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol. Jul. 1977;36(1):59-74. doi: 10.1099/0022-1317-36-1-59.
[cited by applicant]
Grant et al., Perineural antinociceptive effect of opioids in a rat model. Acta Anaesthesiol Scand. Aug. 2001;45(7):906-10. doi: 10.1034/j.1399-6576.2001.045007906.x.
[cited by applicant]
Hackel et al., Transient opening of the perineurial barrier for analgesic drug delivery. Proc Natl Acad Sci U S A. Jul. 17, 2012;109(29):E2018-27. doi: 10.1073/pnas.1120800109. Epub Jun. 25, 2012.
[cited by applicant]
Halkier-Sorensen et al., The relevance of low skin temperature inhibiting histamine-induced itch to the location of contact urticarial symptoms in the fish processing industry. Contact Dermatitis. Sep. 1989;21(3):179-83.
[cited by applicant]
Hamamoto et al., Antimicrobial activity and stability to proteolysis of small linear cationic peptides with D-amino acid substitutions. Microbiol Immunol. 2002;46(11):741-9. doi: 10.1111/j.1348-0421.2002.tb02759.x.
[cited by applicant]
Han et al., Efficacy and safety of high concentration lidocaine for trigeminal nerve block in patients with trigeminal neuralgia. Int J Clin Pract. Feb. 2008;62(2):248-54. Epub Nov. 23, 2007. (Abstract Only).
[cited by applicant]
Hargreaves et al., A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. Jan. 1988;32(1):77-88.
[cited by applicant]
Hauser, International Medical Editorial Board Consensus Statement on the Use of Prolotherapy for Musculoskeletal Pain. Journal of Prolotherapy. Dec. 2011;3(4): 741-848.
[cited by applicant]
Hirakawa et al., Loss and recovery of the blood-nerve barrier in the rat sciatic nerve after crush injury are associated with expression of intercellular junctional proteins. Exp Cell Res. Apr. 1, 2003;284(2):196-210. d…
[cited by applicant]
Ikenouchi et al., Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol. Dec. 19, 2005;171(6):939-45. doi: 10.1083/jcb.200510043.
[cited by applicant]
Junger et al., Hypertonicity regulates the function of human neutrophils by modulating chemoattractant receptor signaling and activating mitogen-activated protein kinase p38. J Clin Invest. Jun. 15, 1998;101(12):2768-79…
[cited by applicant]
Kanda et al., Chronic inflammatory demyelinating polyneuropathy: decreased claudin-5 and relocated ZO-1. J Neurol Neurosurg Psychiatry. May 2004;75(5):765-9. doi: 10.1136/jnnp.2003.025692.
[cited by applicant]
Kasza et al., Medical Ice Slurry Coolants for Inducing Targeted-Organ/Tissue Protective Cooling. Argonne National Labratory. Jun. 2008. 9 pages.
[cited by applicant]
Kauffeld et al., Ice Slurry Applications. Int J Refrig. Dec. 1, 2010;33(8):1491-1505.
[cited by applicant]
Kondoh et al., A novel strategy for the enhancement of drug absorption using a claudin modulator. Mol Pharmacol. Mar. 2005;67(3):749-56. doi: 10.1124/mol. 104.008375. Epub Dec. 15, 2004.
[cited by applicant]
Krause et al., Structure and function of claudins. Biochim Biophys Acta. Mar. 2008;1778(3):631-45. doi: 10.1016/j.bbamem.2007.10.018. Epub Oct. 25, 2007.
[cited by applicant]
Kucenas et al., CNS-derived glia ensheath peripheral nerves and mediate motor root development. Nat Neurosci. Feb. 2008;11(2):143-51. doi: 10.1038/nn2025. Epub Jan. 6, 2008.
[cited by applicant]
Labuz et al., Immune cell-derived opioids protect against neuropathic pain in mice. J Clin Invest. Feb. 2009;119(2):278-86. doi: 10.1172/JCI36246. Epub Jan. 12, 2009.
[cited by applicant]
Lampe et al., Rapid Induction of Heterogeneous Ice Nucleation in a Biologically Compatible Coolant. Int J Transp Phenom. 2011;12(3-4):307-317.
[cited by applicant]
Langert et al., Strategies for Targeted Delivery to the Peripheral Nerve. Front Neurosci. Nov. 27, 2018;12:887. doi: 10.3389/fnins.2018.00887. eCollection 2018.
[cited by applicant]
Lapid, Syringe-Delivered Tumescent Anesthesia Made Easier. Aesthetic Plast Surg. Aug. 2011;35(4):601-2. doi: 10.1007/s00266-010-9625-4. Epub Nov. 24, 2010.
[cited by applicant]
Laverson, Improving abdominoplasty results: reconstruction of the linea alba sulcus by direct fat excision. Aesthet Surg J. Nov.-Dec. 2006;26(6):682-6. doi: 10.1016/j.asj.2006.10.016.
[cited by applicant]
Lenz et al., The freezing threshold of the peripheral motor nerve: an electrophysiological and light-microscopical study on the sciatic nerve of the rabbit. Cryobiology. Oct. 1975;12(5):486-96.
[cited by applicant]
Levin et al., A pilot study of ice-slurry application for inducing laparoscopic renal hypothermia. BJU Int. Jan. 2007;99(1):166-70. Epub Nov. 10, 2006.
[cited by applicant]
Li et al., Changes in the blood-nerve barrier after sciatic nerve cold injury: indications supporting early treatment. Neural Regen Res. Mar. 2015; 10(3): 419-424. doi: 10.4103/1673-5374.153690:10.4103/1673-5374.153690.
[cited by applicant]
Manasse et al., Myocardial acute and chronic histological modi® cations induced by cryoablation. Eur J Cardiothorac Surg. Mar. 2000;17(3):339-40. doi: 10.1016/s1010-7940(99)00361-9.
[cited by applicant]
Manns et al., Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. Sep. 22, 2001;358(9286):958-65. doi: 10.1016/s…
[cited by applicant]
Marsland et al., Cryogenic damage to peripheral nerves and blood vessels in the rat. Br J Anaesth. Jun. 1983;55(6):555-8. doi: 10.1093/bja/55.6.555.
[cited by applicant]
Mitchell et al., Degeneration of non-myelinated axons in the rat sciatic nerve following lysolecithin injection. Acta Neuropathol. 1982;56(3):187-93.
[cited by applicant]
Modak et al., Agglomeration Control of Ice Particles in Ice-Water Slurry System Using Surfactant Additives. HVAC&R Res. 2002;8(4):453-66.
[cited by applicant]
Morita et al., Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci U S A. Jan. 19, 1999;96(2):511-6. doi: 10.1073/pnas.96.2.511.
[cited by applicant]
Mrsny et al., A key claudin extracellular loop domain is critical for epithelial barrier integrity. Am J Pathol. Apr. 2008;172(4):905-15. doi: 10.2353/ajpath.2008.070698. Epub Mar. 18, 2008.
[cited by applicant]
Ohki et al., Interaction of melittin with lipid membranes. Biochim Biophys Acta. Sep. 14, 1994;1194(2):223-32. doi: 10.1016/0005-2736(94)90303-4.
[cited by applicant]
Oku et al., A simple procedure for the determination of the trapped volume of liposomes. Biochim Biophys Acta. Oct. 7, 1982; 691(2): 332-340.
[cited by applicant]
Peltonen et al., Barriers of the peripheral nerve. Tissue Barriers. Jul. 1, 2013;1(3):e24956. doi: 10.4161/tisb.24956. Epub May 30, 2013.
[cited by applicant]
Piña-Oviedo et al., The normal and neoplastic perineurium: a review. Adv Anat Pathol. May 2008;15(3):147-64. doi: 10.1097/PAP.0b013e31816f8519.
[cited by applicant]
Pradel et al., Cryosurgical treatment of genuine trigeminal neuralgia. Br J Oral Maxillofac Surg. Jun. 2002;40(3):244-7.
[cited by applicant]
Pramanick et al., Excipient Selection In Parenteral Formulation Development. Pharma Times. Mar. 2013;45(3):65-77.
[cited by applicant]
Pummi et al., Tight junction proteins ZO-1, occludin, and claudins in developing and adult human perineurium. J Histochem Cytochem. Aug. 2004;52(8):1037-46. doi: 10.1369/jhc.3A6217.2004.
[cited by applicant]
Rathmell et al., Chapter 14—Intercostal Nerve Block and Neurolysis. Atlas of Image-Guided Intervention in Regional Anesthesia and Pain Medicine. 2012. p. 201-3.
[cited by applicant]
Rengachary et al., Effect of glycerol on peripheral nerve: an experimental study. Neurosurgery. Dec. 1983;13(6):681-8. doi: 10.1227/00006123-198312000-00012.
[cited by applicant]
Richner et al., Functional and Structural Changes of the Blood-Nerve-Barrier in Diabetic Neuropathy. Front Neurosci. Jan. 14, 2019;12:1038. doi: 10.3389/fnins.2018.01038. eCollection 2018.
[cited by applicant]
Rousset et al., Presence and cell growth-related variations of glycogen in human colorectal adenocarcinoma cell lines in culture. Cancer Res. Feb. 1979;39(2 Pt 1):531-4.
[cited by applicant]
Sagie et al., Prolonged sensory-selective nerve blockade. Proc Natl Acad Sci U S A. Feb. 23, 2010;107(8):3740-5. doi: 10.1073/pnas.0911542107. Epub Feb. 4, 2010.
[cited by applicant]
Santamaria et al., Tetrodotoxin, epinephrine, and chemical permeation enhancer combinations in peripheral nerve blockade. Anesth Analg. Jun. 2017;124(6):1804-1812. doi: 10.1213/ANE.0000000000002072.
[cited by applicant]
Segev et al., Endocardial cryotherapy as a novel strategy of improving myocardial perfusion in a patient with severe coronary artery disease. Catheter Cardiovasc Interv. Oct. 2003;60(2):229-32. doi: 10.1002/ccd.10621.
[cited by applicant]
Shikanov et al., Microparticulate ice slurry for renal hypothermia: laparoscopic partial nephrectomy in a porcine model. Urology. Oct. 2010;76(4):1012-6. doi: 10.1016/j.urology.2009.12.066. Epub Mar. 31, 2010.
[cited by applicant]
Simons et al., Effect of chemical permeation enhancers on nerve blockade. Mol Pharm. Jan.-Feb. 2009;6(1):265-73. doi: 10.1021/mp800167a.
[cited by applicant]
Sloviter et al., Effects of the intravenous administration of glycerol solutions to animals and man. J Clin Invest. May 1958;37(5):619-26. doi: 10.1172/JCI103644.
[cited by applicant]
Sonoda et al., Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier. J Cell Biol. Oct. 4, 1999;147(1):…
[cited by applicant]
Stein et al., Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin. J Neurosci. Apr. 1990;10(4):1292-8. doi: 10.1523/JNEUROSCI.10-04-01292.1990.
[cited by applicant]
Stevens et al., Molecular and Histological Evidence Detailing Clinically Observed Skin Improvement Following Cryolipolysis. Aesthet Surg J. May 17, 2021;sjab226. doi: 10.1093/asj/sjab226. Online ahead of print.
[cited by applicant]
Stevens, Does Cryolipolysis Lead to Skin Tightening? A First Report of Cryodermadstringo. Aesthet Surg J. Aug. 2014;34(6):NP32-4. doi: 10.1177/1090820X14539699. Epub Aug. 1, 2014.
[cited by applicant]
Sugiritama, Histology of Nervous System. Educational Staff at Medical Faculty of Udayana University. Published Jun. 23, 2009 (available at https://www.slideshare.net/sugiritama/histologic-structure-of-nervous-system).
[cited by applicant]
Suzuki et al., Particle Size Depression and Drag Reduction of Ice Slurry Treated with Combination Additives of Surfactants and Poly(vinyl alcohol). J Chem Eng Jap. 2010;43(6):482-6.
[cited by applicant]
Takahashi et al., Role of C-terminal regions of the C-terminal fragment of Clostridium perfringens enterotoxin in its interaction with claudin-4. ontrol Release. Nov. 2, 2005;108(1):56-62. doi: 10.1016/j.jconrel.2005.07…
[cited by applicant]
Todd et al., Ionic permeability of the frog sciatic nerve perineurium: parallel studies of potassium and Ianthanum penetration using electrophysiological and electron microscopic techniques. J Neurocytol. Aug. 2000;29(8…
[cited by applicant]
Van Eps et al., Distal limb cryotherapy for the prevention of acute laminitis. Clin Tech Equine Pract. Mar. 1, 2004;3(1):64-70.
[cited by applicant]
Vanden Hoek et al., Induced hypothermia by central venous infusion: saline ice slurry versus chilled saline. Crit Care Med. Sep. 2004;32(9 Suppl):S425-31.
[cited by applicant]
Vietor et al., Perturbation of the tight junction permeability barrier by occludin loop peptides activates beta-catenin/TCF/LEF-mediated transcription. EMBO Rep. Apr. 2001;2(4):306-12. doi: 10.1093/embo-reports/kve066.
[cited by applicant]
Weerasuriya et al., Modification of permeability of frog perineurium to [14C]-sucrose by stretch and hypertonicity. Brain Res. Sep. 21, 1979;173(3):503-12. doi: 10.1016/0006-8993(79)90244-0.
[cited by applicant]
Wen et al., Selective decrease in paracellular conductance of tight junctions: role of the first extracellular domain of claudin-5. Mol Cell Biol. Oct. 2004;24(19):8408-17. doi: 10.1128/MCB.24.19.8408-8417.2004.
[cited by applicant]
Winkler et al., Molecular determinants of the interaction between Clostridium perfringens enterotoxin fragments and claudin-3. J Biol Chem. Jul. 10, 2009;284(28):18863-72. doi: 10.1074/jbc.M109.008623. Epub May 8, 2009.
[cited by applicant]
Wong et al., A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol. Jan. 27, 1997;136(2):399-409. doi: 10.1083/jcb.136.2.399.
[cited by applicant]
Wong et al., Targeted and reversible disruption of the blood-testis barrier by an FSH mutant-occludin peptide conjugate. FASEB J. Feb. 2007;21(2):438-48. doi: 10.1096/fj.05-4144com. Epub Dec. 13, 2006.
[cited by applicant]
Wu et al., Identification of new claudin family members by a novel PSI-BLAST based approach with enhanced specificity. Proteins. Dec. 1, 2006;65(4):808-15. doi: 10.1002/prot.21218.
[cited by applicant]
Yamamoto et al., Adipose depots possess unique developmental gene signatures. Obesity (Silver Spring). May 2010;18(5):872-878. doi: 10.1038/oby.2009.512. Epub Jan. 28, 2010. Erratum in:Obesity (Silver Spring). May 2010;…
[cited by applicant]
Yang et al., Getting Drugs across Biological Barriers. Adv Mater. Oct. 2017;29(37):10.1002/adma.201606596. doi: 10.1002/adma.201606596. Epub Jul. 28, 2017.
[cited by applicant]
Yao et al., Medical Polymer Materials. Chemical Industry Press. Apr. 30, 2008;908-10.
[cited by applicant]
Zelickson et al., Cryolipolysis for Noninvasive Fat Cell Destruction: Initial Results from a Pig Model. Dermatol Surg. Oct. 2009;35(10):1462-70. doi: 10.1111/j.1524-4725.2009.01259.x. Epub Jul. 13, 2009.
[cited by applicant]
Zimmermann, Ethical guidelines for investigations of experimental pain in conscious animals. Pain. Jun. 1983;16(2):109-110. doi: 10.1016/0304-3959(83)90201-4.
[cited by applicant]
Zollner et al., Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons. Mol Pharmacol. Aug. 2003;64(2):202-10. doi: 10.1124/mol.64.2.202.
[cited by applicant]
Zwanziger et al., A peptidomimetic tight junction modulator to improve regional analgesia. Mol Pharm. Jun. 4, 2012;9(6):1785-94. doi: 10.1021/mp3000937. Epub May 10, 2012.
[cited by applicant]
U.S. Appl. No. 17/629,206, filed Jan. 21, 2022, Anderson et al.
[cited by applicant]
U.S. Appl. No. 15/505,039, filed Feb. 17, 2017, Garibyan et al.
[cited by applicant]
U.S. Appl. No. 17/236,567, filed Apr. 21, 2021, Garibyan et al.
[cited by applicant]
U.S. Appl. No. 15/505,042, filed Feb. 17, 2017, Garibyan et al.
[cited by applicant]
U.S. Appl. No. 17/188,359, filed Mar. 1, 2021, Garibyan et al.
[cited by applicant]
U.S. Appl. No. 16/288,073, filed Feb. 27, 2019, Garibyan et al.
[cited by applicant]
U.S. Appl. No. 17/535,493, filed Nov. 24, 2021, Garibyan et al.
[cited by applicant]
U.S. Appl. No. 17/966,668, filed Oct. 14, 2022, Garibyan et al.
[cited by applicant]
U.S. Appl. No. 16/327,266, filed Feb. 21, 2019, Anderson et al.
[cited by applicant]
U.S. Appl. No. 17/861,138, filed Jul. 8, 2022, Anderson et al.
[cited by applicant]
U.S. Appl. No. 17/794,934, filed Jul. 22, 2022, Anderson et al.
[cited by applicant]
PCT/US2011/024766, Feb. 14, 2011, The General Hospital Corporation.
[cited by applicant]
U.S. Appl. No. 13/574,425, filed Mar. 15, 2013, Avram et al.
[cited by applicant]
U.S. Appl. No. 15/970,789, filed May 3, 2018, Avram et al.
[cited by applicant]
PCT/US2020/043280, Nov. 9, 2020, International Search Report and Written Opinion.
[cited by applicant]